Marimed (MRMD) Change in Accured Expenses (2011 - 2026)
Marimed (MRMD) posted quarterly Change in Accured Expenses of $829000.0 for Q1 2026, down 56.09% year-over-year from $1.9 million in Q1 2025, and up 220.08% quarter-over-quarter from $259000.0 in Q4 2025.
Marimed (MRMD) Change in Accured Expenses (2011 - 2026) Analysis & Trends
Marimed (MRMD) has reported Change in Accured Expenses for 16 consecutive years, with $829000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 56.09% year-over-year to $829000.0; the TTM figure through Mar 2026 stood at $2.1 million (down 17.56% YoY), while the FY2025 annual figure was $3.2 million, up 80.27% from the prior year.
- Change in Accured Expenses climbed to $829000.0 in Q1 2026 per MRMD's latest filing, from $259000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $1.9 million in Q1 2025 and bottomed at -$1.7 million in Q4 2023.
- Historically, Change in Accured Expenses has averaged $201352.9 across 5 years, with a median of -$136000.0 in 2024.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses slumped 845.83% — and 2024, when it jumped 627.05%.
- Marimed's Change in Accured Expenses stood at -$289000.0 in 2022, then plunged by 491.0% to -$1.7 million in 2023, then surged by 39.58% to -$1.0 million in 2024, then surged by 125.1% to $259000.0 in 2025, then soared by 220.08% to $829000.0 in 2026.
- Business Quant data shows MRMD's Change in Accured Expenses at $829000.0 in Q1 2026, $259000.0 in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Marimed | 30.77 Mn | 22.33 Mn | 16.23 Mn | -81,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -81,000.00 |
| Jun 30, 2026 | -81,000.00 |
| Mar 31, 2026 | 829,000.00 |
| Mar 31, 2026 | 829,000.00 |
| Dec 31, 2025 | 259,000.00 |
| Dec 31, 2025 | 259,000.00 |
| Sep 30, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | -281,000.00 |
| Jun 30, 2025 | -281,000.00 |
| Mar 31, 2025 | 1.89 Mn |
| Mar 31, 2025 | 1.89 Mn |
| Dec 31, 2024 | -1.03 Mn |
| Dec 31, 2024 | -1.03 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | -136,000.00 |
| Jun 30, 2024 | -136,000.00 |
| Mar 31, 2024 | 1.09 Mn |
| Mar 31, 2024 | 1.09 Mn |